Mammalian Cell Fermentation Technology Market Outlook 2024-2033: Trends and Projections

Market Size –
The mammalian cell fermentation technology market size has grown rapidly in recent years. It will grow from $46.05 billion in 2023 to $51.29 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increased demand for biologics and biosimilars, increased focus on personalized medicine, increased output of biopharmaceuticals, and increased demand for scalable and effective cell culture methods.

The mammalian cell fermentation technology market size is expected to see rapid growth in the next few years. It will grow to $80.16 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to the increasing prevalence of chronic diseases, rising investments by multinational corporations, rising frequency of chronic diseases, increasing adoption of advanced bioprocessing techniques, increasing investment in research and development of novel recombinant proteins and growing demand for cancer therapies. Major trends in the forecast period include technological advancements in cell culture, technological advancements in bioreactor design, developing next-generation bioprocessing technologies, integration of multi-omics approaches, and technology-driven automation.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/mammalian-cell-fermentation-technology-global-market-report

Scope Of Mammalian Cell Fermentation Technology Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Mammalian Cell Fermentation Technology Market Overview

Market Drivers –
The growing demand for biologics is expected to propel the growth of the mammalian cell fermentation technology market going forward. Biologics are medical products derived from living organisms or their components, often used to treat diseases such as cancer, autoimmune disorders, and infectious diseases. The increasing demand for biologics is fueled by advancements in biotechnology and their effectiveness in treating prevalent chronic diseases such as cancer and autoimmune disorders, regulatory approvals, and growing investment in research and development. Mammalian cell fermentation technology efficiently produces complex biologics, meeting the growing demand for personalized and targeted therapeutics. Its scalability, versatility, and ability to produce high-quality proteins drive innovation in the biopharmaceutical industry. For instance, in February 2024, according to the National Library of Medicine, a US-based medical library, in 2023, the Food and Drug Administration (FDA) approved 55 new drugs, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the growing demand for biologics is driving the growth of the bacterial cell fermentation technology market.

Market Trends –
Major companies operating in the mammalian cell fermentation technology market are focusing on developing innovative technologies, such as mammalian cell culture, to strengthen their position in the market. A mammalian cell culture is a crucial tool in various fields, including biomanufacturing, research, and regenerative medicine, as it enables the production of therapeutic proteins, vaccines, and functional cells or tissue analogs. For instance, in February 2021, Culture Bioscience, a US-based biotechnology company, introduced cloud bioreactors for mammalian cell culture. This innovative technology provides a fully cloud-based platform for scalable cell culture research, which marks a paradigm leap in bioprocessing. These cloud bioreactors provide real-time data analysis and decision-making from any location with internet access by utilizing remote monitoring and control technologies to improve scalability, flexibility, and collaboration in the development of bioprocesses and biomanufacturing.

The mammalian cell fermentation technology market covered in this report is segmented –

1) By Type: Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types
2) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Other Applications
3) By End-Use: Biopharmaceutical Companies, Contract Research Organizations And Contract Development and Manufacturing Organizations, Academic And Research Institutes

Get an inside scoop of the mammalian cell fermentation technology market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp

Regional Insights –
North America was the largest region in the mammalian cell fermentation technology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the mammalian cell fermentation technology market are <b>AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc</b>

Table of Contents
1. Executive Summary
2. Mammalian Cell Fermentation Technology Market Report Structure
3. Mammalian Cell Fermentation Technology Market Trends And Strategies
4. Mammalian Cell Fermentation Technology Market – Macro Economic Scenario
5. Mammalian Cell Fermentation Technology Market Size And Growth
…..
27. Mammalian Cell Fermentation Technology Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model